Genenta Science srl:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Genenta Science srl - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10980
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genenta Science srl (Geneta Science) is a biotechnology company that develops gene therapies based on transcriptional and mirRNA-mediated controls. The company develops gene transfer strategy into autologous hematopoietic stem and progenitor cells in order to target interferon-a expression to tumor-infiltrating monocytes and macrophages. Its gene is delivered into the HSPCs using viral vector, Lentivirus. The company’s gene therapy utilizes a combination of transcriptional and microRNA-mediated control that allows tumor-infiltrating monocytes and macrophages to selectively express the tumor area reducing the high toxicity of normally toxic interferon. Geneta Science is headquartered in Milan, Italy.

Genenta Science srl – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genenta Science srl, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genenta Science srl, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Genenta Science srl, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Genenta Science Raises USD8.4 Million in Series B Financing 10
Genenta Science Raises USD11.5 Million in Series A Financing 11
Partnerships 12
Genenta Science and San Raffaele Hospital Enter into Agreement with Amgen 12
MolMed Enters into Co-Development Agreement with Genenta Science 13
Genenta Science srl – Key Competitors 14
Genenta Science srl – Key Employees 15
Genenta Science srl – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Genenta Science srl, Pharmaceuticals & Healthcare, Key Facts 2
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genenta Science srl, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genenta Science srl, Deals By Therapy Area, 2012 to YTD 2018 8
Genenta Science srl, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Genenta Science Raises USD8.4 Million in Series B Financing 10
Genenta Science Raises USD11.5 Million in Series A Financing 11
Genenta Science and San Raffaele Hospital Enter into Agreement with Amgen 12
MolMed Enters into Co-Development Agreement with Genenta Science 13
Genenta Science srl, Key Competitors 14
Genenta Science srl, Key Employees 15
Genenta Science srl, Other Locations 16

List of Figures
Genenta Science srl, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genenta Science srl, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Genenta Science srl:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kina Petroleum Ltd (KPL)-石油・ガス分野:企業M&A・提携分析
    Summary Kina Petroleum Limited (KPL) is an upstream oil and gas company that focuses on exploration, development and production activities. It has operations in Papua New Guinea (PNG) and Australia. The company focuses on participating in highly prospective oil and gas acreage positions near to prov …
  • Jacobs Engineering Group Inc (J):企業の財務・戦略的SWOT分析
    Jacobs Engineering Group Inc (J) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Phio Pharmaceuticals Corp (RXII):企業の財務・戦略的SWOT分析
    Summary Phio Pharmaceuticals Corp (Phio Pharmaceuticals), formerly known as RXi Pharmaceuticals Corp, is a biotechnology company. It discovers, develops and commercializes immuno-oncology therapeutics based RNAi platform to treat cancer. Its product pipeline includes PH-762, PH-894 and PH-804 for ad …
  • First Solar Inc (FSLR)-エネルギー分野:企業M&A・提携分析
    Summary First Solar, Inc. (First Solar) is a provider of photovoltaic (PV) solar energy solutions. It designs, manufactures and sells PV solar modules with an advanced thin-film semiconductor technology; and also develops, designs, constructs and sells PV solar power systems. The company uses its Cd …
  • Symrise AG (SY1):企業の財務・戦略的SWOT分析
    Symrise AG (SY1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Stemcor Global Holdings Ltd:企業の戦略・SWOT・財務情報
    Stemcor Global Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Stemcor Global Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • YTL Power International Bhd (YTLPOWR)
    YTL Power International Bhd (YTLPOWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Shire plc:企業のM&A・事業提携・投資動向
    Shire plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shire plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Bio Techne Corp (TECH)-医療機器分野:企業M&A・提携分析
    Summary Bio Techne Corp (Bio Techne), develops manufactures and sells biotechnology products and instruments for research and clinical diagnostics. The company provides proteins and antibodies, and related immunoassays and other reagents for research under brands such as R&D Systems, Novus, Biologic …
  • ScinoPharm Taiwan Ltd (1789):製薬・医療:M&Aディール及び事業提携情報
    Summary ScinoPharm Taiwan Ltd (ScinoPharm) provides process research and development (R&D) and active pharmaceutical ingredient (API) manufacturing services to the pharmaceutical industry. It services include custom synthesis for early phase pharmaceutical activities, brand companies and APIs for th …
  • Fujirebio Diagnostics Inc:企業の製品パイプライン分析
    Summary Fujirebio Diagnostics Inc (FDI), a subsidiary of Fujirebio Inc is a healthcare diagnostic company that manufactures, markets and develops biomarker assays and in-vitro diagnostic products. The company’s products include OEM custom solutions, manual kits, serum products, multi-constituent con …
  • LuLu Group International:企業の戦略・SWOT・財務情報
    LuLu Group International - Strategy, SWOT and Corporate Finance Report Summary LuLu Group International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • China Meheco Co Ltd:企業の戦略・SWOT・財務情報
    China Meheco Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Meheco Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Delta Air Lines Inc:戦略・SWOT・企業財務分析
    Delta Air Lines Inc - Strategy, SWOT and Corporate Finance Report Summary Delta Air Lines Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Einstein Noah Restaurant Group, Inc. (Foodservice):企業の戦略・SWOT・財務情報
    Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Jadason Enterprises Ltd (J03):企業の財務・戦略的SWOT分析
    Jadason Enterprises Ltd (J03) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Assam Company India Ltd (ASSAMCO):企業の財務・戦略的SWOT分析
    Assam Company India Ltd (ASSAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Takeda Pharmaceutical Co Ltd (4502):企業の財務・戦略的SWOT分析
    Takeda Pharmaceutical Co Ltd (4502) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Madico Inc:企業の戦略的SWOT分析
    Madico Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Milagen Inc:企業の製品パイプライン分析
    Summary Milagen Inc (Milagen) is a medical device company. It provides diagnostic products. The company generates antibody reagents against the human proteome. It discovers, develops and markets non invasive immunodiagnostic products for monitoring, surveillance and detection of cancers. Milagen off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆